| NDC Code | 42227-081-05 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (42227-081-05) / 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) |
|---|
| Product NDC | 42227-081 |
|---|
| Product Type Name | PLASMA DERIVATIVE |
|---|
| Proprietary Name | Cinryze |
|---|
| Non-Proprietary Name | Human C1-esterase Inhibitor |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20081201 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125267 |
|---|
| Manufacturer | Takeda Pharmaceuticals America, Inc. |
|---|
| Substance Name | HUMAN C1-ESTERASE INHIBITOR |
|---|
| Strength | 500 |
|---|
| Strength Unit | [iU]/5mL |
|---|
| Pharmacy Classes | Decreased Vascular Permeability [PE], Human C1 Esterase Inhibitor [EPC], Kallikrein Inhibitors [MoA] |
|---|